Anticoagulation does not increase risk of mortality or ICU admission in hospitalized COVID-19 patients with gastrointestinal bleeding: Results from a New York health system - 14/05/21
Doi : 10.1016/j.clinre.2020.101602
Sheila D. Rustgi
Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Jeong Yun Yang
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Sanjana Luther, Yakira David, Rebekah E. Dixon, Priya K. Simoes, Nikhil A. Kumta ⁎ 
Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
⁎Corresponding author at: Associate Professor of Medicine, Director of Surgical and Bariatric Endoscopy, Henry D. Janowitz Division of Gastroenterology, Mount Sinai Hospital, One Gustave L. Levy Place, Box 1069 New York, NY 10029-6574, United States.Associate Professor of Medicine, Director of Surgical and Bariatric Endoscopy, Henry D. Janowitz Division of Gastroenterology, Mount Sinai HospitalOne Gustave L. Levy Place, Box 1069New YorkNY10029-6574United States
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Keywords : COVID-19, Gastrointestinal bleeding, Anticoagulation
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2020
Elsevier Masson SAS. Tutti i diritti riservati.
Vol 45 - N° 3
Articolo 101602- Maggio 2021 Ritorno al numero
Articolo precedente
- Covid-19 and hepatic injury: A systematic review
- Francesco Serra, Isabella Bonaduce, Nicola De ruvo, Nicola Cautero, Lucio Brugioni, Roberta Gelmini
- Impact of delayed transit in severe COVID 19 critical care patients: A retrospective analysis
- Dominique Prat, Frédéric Jacobs, Olfa Hamzaoui, Charles Damoisel, Benjamin Sztrymf
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.